CPA4
CPA4 (carboxypeptidase A4, also known as CPA3) is a secreted zinc-dependent metalloprotease of the M14 carboxypeptidase group. It removes hydrophobic residues from the C-terminus of peptides and may contribute to peptide hormone and neuropeptide catabolism. Browse Assay Genie's current range of CPA4 research reagents below, or read on for the biology behind the target.
CPA4 is a metalloprotease that cleaves hydrophobic C-terminal residues from its substrates, with a preference for phenylalanine, leucine, isoleucine, methionine, tyrosine and valine at the terminus. It is a secreted enzyme, and UniProt notes that it may function in the catabolism of peptide hormones and/or neuropeptides. Like other carboxypeptidases, it is a zinc-containing exopeptidase that catalyses the release of carboxy-terminal amino acids, and it is synthesised as a zymogen that is activated by proteolytic cleavage.
The CPA4 gene encodes a member of the carboxypeptidase A/B subfamily and belongs to the peptidase M14 family, listed by HGNC in the M14 carboxypeptidases gene group. It sits in a cluster with three other family members on chromosome 7, which is consistent with the neighbouring carboxypeptidase A genes such as CPA1, CPA2 and CPA5. Researchers studying the CPA4 protein often compare it with these related enzymes, since their substrate preferences and roles differ.
NCBI Gene summarises that the CPA4 gene could be involved in the histone hyperacetylation pathway. It is also reported to be imprinted and may be a strong candidate gene for prostate cancer aggressiveness. CPA3 is listed as an alias for this gene, so literature using that symbol should be read with care to avoid confusion with other carboxypeptidase A family members. The mouse ortholog is Cpa4.
CPA4 is described as a strong candidate gene for prostate cancer aggressiveness, making it a subject of interest in tumour biology.
CPA4 may take part in peptide hormone and neuropeptide catabolism by removing hydrophobic C-terminal residues.
CPA4 could be involved in the histone hyperacetylation pathway, linking a secreted protease to chromatin-related questions.
CPA4 is an imprinted gene within a chromosome 7 carboxypeptidase cluster, offering a model for imprinting and gene-cluster analysis.
CPA4 is a secreted metalloprotease that cleaves hydrophobic C-terminal residues, preferring Phe, Leu, Ile, Met, Tyr and Val. As a zinc-containing exopeptidase it releases carboxy-terminal amino acids, and it may function in peptide hormone and neuropeptide catabolism.
The HGNC-approved name is carboxypeptidase A4, and CPA3 is listed as an alias or previous symbol. Because CPA3 is also used for a separate carboxypeptidase A family member, confirm the gene identifier when comparing publications, reagents or datasets.
NCBI Gene reports CPA4 as imprinted and a possible strong candidate gene for prostate cancer aggressiveness. A mouse ortholog, Cpa4, exists; check the datasheet of any product for its validated reactivity.
Other carboxypeptidase A family members from the M14 peptidase group with research products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UI42; product specifications from Assay Genie datasheets.